162 related articles for article (PubMed ID: 1571504)
1. Role of endogenous platelet-activating factor in caerulein-induced acute pancreatitis in rats: protective effects of a PAF-antagonist.
Fujimura K; Kubota Y; Ogura M; Yamaguchi T; Binnaka T; Tani K; Kitagawa S; Mizuno T; Inoue K
J Gastroenterol Hepatol; 1992; 7(2):199-202. PubMed ID: 1571504
[TBL] [Abstract][Full Text] [Related]
2. Platelet activating factor (PAF) inhibitor (TCV-309) reduces caerulein- and PAF-induced pancreatitis. A morphologic and functional study in the rat.
Tomaszewska R; Dembiński A; Warzecha Z; Banaś M; Konturek SJ; Stachura J
J Physiol Pharmacol; 1992 Dec; 43(4):345-52. PubMed ID: 1294265
[TBL] [Abstract][Full Text] [Related]
3. Role of platelet activating factor in pathogenesis of acute pancreatitis in rats.
Konturek SJ; Dembinski A; Konturek PJ; Warzecha Z; Jaworek J; Gustaw P; Tomaszewska R; Stachura J
Gut; 1992 Sep; 33(9):1268-74. PubMed ID: 1385272
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor mediates pancreatic function derangement in caerulein-induced pancreatitis in rats.
Alonso R; Montero A; Arévalo M; García LJ; Sánchez-Vicente C; Rodríguez-Nodal F; López-Novoa JM; Calvo JJ
Clin Sci (Lond); 1994 Jul; 87(1):85-90. PubMed ID: 7520381
[TBL] [Abstract][Full Text] [Related]
5. Role of endogenous platelet-activating factor in the regulation of pancreatic blood flow during caerulein stimulation.
Ogura M; Kubota Y; Inoue K
J Gastroenterol; 1996 Jun; 31(3):414-9. PubMed ID: 8726834
[TBL] [Abstract][Full Text] [Related]
6. Platelet-activating factor antagonist (TCV-309) attenuates the priming effects of bronchoalveolar macrophages in cerulein-induced pancreatitis rats.
Yamaguchi Y; Matsumura F; Liang J; Okabe K; Matsuda T; Ohshiro H; Ishihara K; Akizuki E; Yamada S; Ogawa M
Pancreas; 1999 May; 18(4):355-63. PubMed ID: 10231840
[TBL] [Abstract][Full Text] [Related]
7. Role of endogenous platelet-activating factor(PAF) in stress-induced hemorrhagic pancreatitis in rats.
Kimura T; Furukawa M; Arita Y; Takano S; Yamaguchi H; Sumii T; Nawata H
Gastroenterol Jpn; 1991 Feb; 26(1):100. PubMed ID: 2007454
[No Abstract] [Full Text] [Related]
8. Platelet-activating factor involvement in the aggravation of acute pancreatitis in rabbits.
Yotsumoto F; Manabe T; Kyogoku T; Hirano T; Ohshio G; Yamamoto M; Imamura T; Yoshitomi S
Digestion; 1994; 55(4):260-7. PubMed ID: 7520402
[TBL] [Abstract][Full Text] [Related]
9. Effects of the bradykinin antagonist, icatibant (Hoe 140), on pancreas and liver functions during and after caerulein-induced pancreatitis in rats.
Griesbacher T; Kolbitsch C; Tiran B; Lembeck F
Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):557-64. PubMed ID: 8751086
[TBL] [Abstract][Full Text] [Related]
10. "Cocktail" therapy for acute pancreatitis: combined therapy of protease inhibitor, xanthine oxidase inhibitor and platelet activating factor antagonist in rat caerulein-induced pancreatis.
Hirano T; Manabe T
Nihon Geka Hokan; 1992 Nov; 61(6):433-44. PubMed ID: 1306981
[TBL] [Abstract][Full Text] [Related]
11. Allopurinol attenuates caerulein induced acute pancreatitis in the rat.
Wisner JR; Renner IG
Gut; 1988 Jul; 29(7):926-9. PubMed ID: 2456257
[TBL] [Abstract][Full Text] [Related]
12. Protection by gabexate mesilate (FOY) of the exocrine pancreas in rats with acute pancreatitis induced by a supramaximal dose of caerulein.
Hirano T; Manabe T; Tobe T
J Gastroenterol Hepatol; 1991; 6(3):260-4. PubMed ID: 1717033
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor: a mediator of pancreatic inflammation during cerulein hyperstimulation.
Zhou W; Levine BA; Olson MS
Am J Pathol; 1993 May; 142(5):1504-12. PubMed ID: 8494049
[TBL] [Abstract][Full Text] [Related]
14. Evidence for platelet-activating factor as a late-phase mediator of chronic pancreatitis in the rat.
Zhou WG; Chao W; Levine BA; Olson MS
Am J Pathol; 1990 Dec; 137(6):1501-8. PubMed ID: 1701964
[TBL] [Abstract][Full Text] [Related]
15. Effect of platelet-activating factor antagonist WEB 2086 on microcirculatory disorders in acute experimental pancreatitis of graded severity.
Mann O; Tiefenbacher WJ; Kaifi J; Schneider C; Kluth D; Bloechle C; Yekebas E; Izbicki JR; Strate T
Pancreas; 2009 Jan; 38(1):58-64. PubMed ID: 18695628
[TBL] [Abstract][Full Text] [Related]
16. Protective action of lipopolysaccharidesin rat caerulein-induced pancreatitis: role of nitric oxide.
Jaworek J; Jachimczak B; Tomaszewska R; Konturek PC; Pawlik WW; Sendur R; Hahn EG; Stachura J; Konturek SJ
Digestion; 2000; 62(1):1-13. PubMed ID: 10899719
[TBL] [Abstract][Full Text] [Related]
17. Histologic and biochemical alterations in experimental acute pancreatitis induced by supramaximal caerulein stimulation.
Tani S; Otsuki M; Itoh H; Fujii M; Nakamura T; Oka T; Baba S
Int J Pancreatol; 1987; 2(5-6):337-48. PubMed ID: 2447208
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of a PAF receptor antagonist and a neutrophil elastase inhibitor on multiple organ failure induced by cerulein plus lipopolysaccharide in rats.
Yamano M; Umeda M; Miyata K; Yamada T
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):253-63. PubMed ID: 9750012
[TBL] [Abstract][Full Text] [Related]
19. Influence of adenosine receptors on the development of caerulein-induced acute pancreatitis.
Szczerbiński M; Celiński K; Słomka M; Kasztelan-Szczerbińska B; Cichoz-Lach H
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):245-56. PubMed ID: 12898930
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a role of oxygen derived free radicals in the pathogenesis of caerulein induced acute pancreatitis in rats.
Wisner J; Green D; Ferrell L; Renner I
Gut; 1988 Nov; 29(11):1516-23. PubMed ID: 3209108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
